Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lavior Diabetic Wound Gel
- Development stage
- Phase 3
- Lead developer
- Lavior Pharma
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Hydrogel Systems → Drug Delivery Systems, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Lavior Diabetic Wound Gel is a topical botanical-based therapeutic developed by Lavior Pharma for the management of diabetic foot ulcers and other chronic wounds. The formulation is based on a proprietary extract of *Inula viscosa* (Dittrichia viscosa), a Mediterranean plant known for its anti-inflammatory, antimicrobial, and antioxidant properties. The gel is designed to maintain a moist wound environment, reduce local inflammation, and prevent secondary infections, thereby facilitating tissue regeneration and accelerating the healing of non-healing wounds. It is currently being evaluated in clinical trials, such as the RENEW study, to demonstrate its efficacy and non-inferiority compared to standard hydrogel treatments.
- Brand names
- Lavior Diabetic Wound Gel
- Other names
- Lavior D-Wound CareLavior Diabetic Wound Care Gel
Beyond the preview
Go deeper on Lavior Diabetic Wound Gel.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lavior Diabetic Wound Gel.